NCT07604376 Comparative Analysis of the Impact of Transversus Abdominis Plane Block on Post-Cesarean Pain Management Using Low Concentration Ropivacaine 0,2%
| NCT ID | NCT07604376 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Matild Keresztes |
| Condition | Postoperative Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 70 participants |
| Start Date | 2024-03-01 |
| Primary Completion | 2026-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 70 participants in total. It began in 2024-03-01 with a primary completion date of 2026-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to evaluate whether the addition of a Transversus Abdominis Plane (TAP) block improves postoperative outcomes in women undergoing cesarean section. The main questions it aims to answer are: Does the TAP block reduce postoperative pain scores compared with the traditional analgesic regimen used in our hospital? Does the TAP block decrease opioid consumption within the first 24 hours? Does the TAP block improve the 24-hour quality of recovery? Researchers will compare patients receiving the traditional analgesic regimen with patients who receive the TAP block in addition to standard care to determine differences in pain management, opioid requirements, and recovery quality. Participants will: Receive standard anesthetic and perioperative care for cesarean delivery. Be randomized to either the TAP block group or the traditional analgesic regimen group. Have postoperative pain scores assessed at predefined intervals. Have opioid consumption recorded within the first 24 hours. Complete a quality-of-recovery assessment at 24 hours postoperatively.
Eligibility Criteria
Inclusion Criteria: pregnant patient anaesthesia type for c-section: spinal Exclusion Criteria: general anaesthesia for c-section combined spinal/epidural anaethesia for c-section hipertensive emergencies in obstetrics haemorrhage emergencies in obstetrics
Contact & Investigator
Janos Szederjesi, MD, PhD Assoc Prof
STUDY DIRECTOR
Department of Anesthesiology and Intensive Care, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Târgu Mureș
Frequently Asked Questions
Who can join the NCT07604376 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Postoperative Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07604376 currently recruiting?
Yes, NCT07604376 is actively recruiting participants. Contact the research team at keresztesmatild@gmail.com for enrollment information.
Where is the NCT07604376 trial being conducted?
This trial is being conducted at Târgu Mureş, Romania.
Who is sponsoring the NCT07604376 clinical trial?
NCT07604376 is sponsored by Matild Keresztes. The principal investigator is Janos Szederjesi, MD, PhD Assoc Prof at Department of Anesthesiology and Intensive Care, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Târgu Mureș. The trial plans to enroll 70 participants.